NCT01631825View on ClinicalTrials.gov

A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Parkinson's Disease
Interventions
DRUG

SPM 962

SPM 962 transdermal patch once a daily up to 36.0 mg/day

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY